Selected News

Centennial Reflections: The Impactful Learning Legacy of John Griffin (McIntire ’85) and Chris Shumway (McIntire ’88)

McIntire News, August 27, 2021

McIntire alumni John Griffin and Chris Shumway are well-known investors and Visiting Scholars who have driven important positive change within UVA, the Commerce School—and the lives of students. In their own way, each has played an important role in helping create a multitude of opportunities for students by sharing the wealth of knowledge they’ve accrued in their remarkable careers in finance.

Read More

Chris Shumway Donates $25M to Harvard to create Biotechnology MBA

Bloomberg, October 20, 2020

Former Tiger Cub Chris Shumway is helping Harvard University prepare a new breed of MBAs, equally at ease on Wall Street and in the laboratory. With a $25 million gift, Shumway and wife Carrie are supporting the joint life sciences MS/MBA program at Harvard Business School that took its first 11 students in August.

Read More

New SPAC Founded By Chris Shumway, John Collins, and Eric Grubman Raises $400M In IPO

SportsPro, September 15, 2020

Eric Grubman and John Collins have formed a special purpose acquisition company (SPAC) targeting the sports and entertainment sectors. Sports Entertainment Acquisition Corp, which also counts US investor Chris Shumway as a co-founder, filed with the securities and exchange commission (SEC) on 14th September for an initial public offering (IPO) it hopes will raise as much as US$350 million.

Read More

Shumway Capital Participates in Finch Therapeutics’s $90M Financing

Business Wire, September 17, 2020

Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome drug development company, announced today a $90 million Series D financing. New investors in the round include Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, Octave Group, and OMX Ventures, along with support from existing investors, including Avenir Growth Capital, OCV Partners, Shumway Capital, SIG, SymBiosis, TPTF, and Willett Advisors.

Read More

Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies

BioSpace, August 22, 2019

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced today the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna International Group (SIG), Symbiosis LLC and the Trans-Pacific Technology Fund, as well as existing investors, including Avenir Growth Capital, Morgan Noble, Shumway Capital, and Willett Advisors.

Read More

Chris Shumway Gives UVA $25 Million to Train Bioscientists in Business

University of Virginia, September 25, 2018

The University of Virginia today announced a $25 million gift from The Chris and Carrie Shumway Foundation to fund an innovative new building and new bioscience/business program.

Read More

Elligo Health Research Raises $16M to Improve Access to Clinical Trials

Business Wire, March 20, 2018

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16 million in Series B funding led by Hatteras Venture Partners and Noro-Moseley Partners with participation from FS Healthcare LLC, Excelerate Health Ventures and all existing Series A investors including Shumway Capital.

Read More

Finch Therapeutics Group Inks $36M in Series B

VC News Daily, March 5, 2018

Privately held microbiome therapeutics company, announced today the successful close of an oversubscribed $36 million Series B financing.

Read More

Bond-Trader TruMid Sells Stake Valuing Company at $75 Million

Bloomberg, March 4, 2015

TruMid Financial LLC raised money from investors in a deal valuing the bond-trading startup at $75 million, according to President Ravi Singh. TruMid is among more than a dozen firms, including Bloomberg News parent Bloomberg LP, trying to help make it easier to trade debt in the $7.7 trillion U.S. corporate bond market. Like its competitors, TruMid is operating in a market reshaped by regulations following the 2008 financial crisis.

Read More

Chris Shumway Goes Long Moody’s at Ira Sohn Conference

Yahoo! News, May 5, 2014

Shares of Moody’s (NYSE: MCO) jump following comments from Chris Shumway at the Ira Sohn Conference. The founder and managing partner of Shumway Capital Partners LLC, Shumway was recognized as a Top 10 performing manager by Barron’s Magazine.

Read More